C3435T polymorphism in the MDR1 gene affects the enterocyte expression level of CYP3A4 rather than Pgp in recipients of living-donor liver transplantation.
about
ATP-binding cassette B1 gene polymorphisms, mRNA expression and chemosensitivity to paclitaxel in non-small cell lung cancer cells.A synonymous polymorphism in a common MDR1 (ABCB1) haplotype shapes protein function.Polymorphisms in DNA repair genes and MDR1 and the risk for non-Hodgkin lymphoma.Relationship between P-glycoprotein and second-generation antipsychotics.Pharmacogenomics of MDR1/ABCB1 gene: the influence on risk and clinical outcome of haematological malignancies.Use of a simplified nomogram to individualize digoxin dosing versus standard dosing practices in patients with heart failure.Multidrug resistance 1 gene in inflammatory bowel disease: a meta-analysis.Meta-Analysis of ABCB1 3435C>T Polymorphism and Colorectal Cancer.Pharmacogenetics of MDR1 and its impact on the pharmacokinetics and pharmacodynamics of drugs.Comparative description of haplotype structure and genetic diversity of MDR1 (ABCB1) in HIV-positive and HIV-negative populations.MDR1 haplotypes derived from exons 21 and 26 do not affect the steady-state pharmacokinetics of tacrolimus in renal transplant patients.Meta-analysis of the influence of MDR1 C3435T polymorphism on digoxin pharmacokinetics and MDR1 gene expression.Differences in drug pharmacokinetics between East Asians and Caucasians and the role of genetic polymorphisms.The ABC transporters MDR1 and MRP2: multiple functions in disposition of xenobiotics and drug resistance.Minimal effect of MDR1 and CYP3A5 genetic polymorphisms on the pharmacokinetics of indinavir in HIV-infected patientsCytochrome P450 3A polymorphisms and immunosuppressive drugs.Mechanisms of resistance to anticancer drugs: the role of the polymorphic ABC transporters ABCB1 and ABCG2.Clinical pharmacogenetics of immunosuppressive drugs in organ transplantation.The pharmacogenetics of calcineurin inhibitors: one step closer toward individualized immunosuppression?Multidrug resistance (MDR1) gene in inflammatory bowel disease: a key player?Genetic polymorphisms of ATP-binding cassette transporters ABCB1 and ABCG2: therapeutic implications.Does pharmacogenetics have the potential to allow the individualisation of immunosuppressive drug dosing in organ transplantation?Single nucleotide polymorphisms in human P-glycoprotein: its impact on drug delivery and disposition.Pharmacogenetic differences and drug-drug interactions in immunosuppressive therapy.ABCB1 genotype and PGP expression, function and therapeutic drug response: a critical review and recommendations for future research.The emerging importance of transporter proteins in the psychopharmacological treatment of the pregnant patient.Association between Genetic Polymorphism of Multidrug Resistance 1 Gene and Sasang ConstitutionsInfluence of ABCB1 polymorphisms and haplotypes on tacrolimus nephrotoxicity and dosage requirements in children with liver transplant.Treatment of steroid-naive ulcerative colitis.ABC transporters in human lymphocytes: expression, activity and role, modulating factors and consequences for antiretroviral therapies.Drug transporter pharmacogenetics in nucleoside-based therapies.Impact of ATP-binding cassette, subfamily B, member 1 pharmacogenetics on tacrolimus-associated nephrotoxicity and dosage requirements in paediatric patients with liver transplant.Potential role of multidrug resistant proteins in refractory epilepsy and antiepileptic drugs interactions.Interplay of pharmacogenetic variations in ABCB1 transporters and cytochrome P450 enzymes.Choosing the right dose of tacrolimus.CYP3A4 and MDR1 alleles in a Portuguese population.Impact of Genetic Polymorphisms of ABCB1 (MDR1, P-Glycoprotein) on Drug Disposition and Potential Clinical Implications: Update of the Literature.Association between MDR1 gene polymorphisms and the risk of Crohn's disease in a cohort of Algerian pediatric patients.Relationship Between ABCB1 Polymorphisms and Cold Pain Sensitivity Among Healthy Opioid-naive Malay Males.Do drug transporter (ABCB1) SNPs and P-glycoprotein function influence cyclosporine and macrolides exposure in renal transplant patients? Results of the pharmacogenomic substudy within the symphony study.
P2860
Q27851666-EB80A46C-AD2E-4E15-84D5-6F7303D1B0FDQ30375556-C4351180-12E0-43B7-81DD-5A652A046B4FQ33580765-2D6EED32-1EBF-4DD0-BEAB-E0945DC9CAC7Q34208133-50443867-297C-4D52-B055-034C85FFB770Q34327594-4C7F81A5-235D-4427-8311-90B989070511Q34490600-B68E31D0-05E0-4923-BD91-02879D311E9CQ34538009-82B90B4E-832C-47F8-9F45-84040FB2D765Q35071734-5B59B6A5-2C80-4884-A2A7-EEAEF1705723Q35164664-16E4BA13-AD50-4CB1-A4A3-ECF0CC89B173Q35295887-35A9E2CA-9382-4E86-B472-181DEE899CD4Q35826490-9DC4C82C-0CD3-417E-A0C6-1F24E8A40088Q35827187-651A623B-3E04-41F0-A5E5-68F2FD5577DBQ35876954-3D257CD9-D914-4396-AE24-660A1F02E4D3Q35956193-75C754A5-E80D-4FBB-80C9-26F291E24962Q36024688-EC8BD058-C365-4551-A7DD-20BE1E59498EQ36050572-27FFC83D-9138-463A-B7A9-B119237E2FCDQ36120816-36AE7DF2-6EEE-4FB1-AFCD-BA5A4404ED2DQ36120833-84BB1EC2-4C9A-4057-9310-516B62CAF9B8Q36186945-4D0FDEBF-A32F-4C14-AF78-8372A69D348BQ36292830-5BEF5406-1CB5-4236-BC73-8BDC7B646625Q36301589-61482AD0-0838-443F-A64C-D84A34FDE99FQ36326210-F7928F6E-995B-474A-AAC7-B3B07AB20818Q36349672-B12EBDD4-44A9-409D-A27F-7AA6A511E844Q36544981-957B9AAC-671E-4059-B3B5-1FAD0DA79FC6Q36592129-50ED2B18-6C38-4706-9182-AD59C299A868Q37024001-A53E21DC-7A3A-42B7-9857-E408ED10E486Q37341572-0D834A40-CC13-4C93-A864-6ED7D142F11EQ37397805-3AFE5433-6BB6-4524-9B4A-0078991CF99AQ37483916-C296131C-6FE3-4CB1-ACCC-611AD2B219A3Q37724178-BFB8FA45-4AE8-4973-8F69-3D22092D6C0AQ37760954-CF184A8A-35A4-46F2-A0ED-E21353B669DFQ37772515-6E516C30-9C0A-4F63-9B7D-A3048838E46EQ37873936-3BDB67A6-ECC5-4E6E-AD8B-DA7D705E895FQ37964574-385F1099-C0A1-4EAA-8E0D-21D9B84D4B1DQ38270520-0C070579-A3D5-4F5F-A0D6-A24C01005F90Q38348695-F1C1EB9E-B565-436C-B497-91F3E1520480Q38414396-D7B0E5B8-963A-4511-A322-ABFEF3F947C0Q39414002-267FD35E-0CD2-4219-A08F-49F91BFA70FDQ44342118-0EF35AB1-992B-4722-BCCE-35D3DD8378CAQ44554143-1020DE34-CBB6-4DCB-9C56-9861947DA111
P2860
C3435T polymorphism in the MDR1 gene affects the enterocyte expression level of CYP3A4 rather than Pgp in recipients of living-donor liver transplantation.
description
2002 nî lūn-bûn
@nan
2002年の論文
@ja
2002年学术文章
@wuu
2002年学术文章
@zh
2002年学术文章
@zh-cn
2002年学术文章
@zh-hans
2002年学术文章
@zh-my
2002年学术文章
@zh-sg
2002年學術文章
@yue
2002年學術文章
@zh-hant
name
C3435T polymorphism in the MDR ...... g-donor liver transplantation.
@en
C3435T polymorphism in the MDR ...... g-donor liver transplantation.
@nl
type
label
C3435T polymorphism in the MDR ...... g-donor liver transplantation.
@en
C3435T polymorphism in the MDR ...... g-donor liver transplantation.
@nl
prefLabel
C3435T polymorphism in the MDR ...... g-donor liver transplantation.
@en
C3435T polymorphism in the MDR ...... g-donor liver transplantation.
@nl
P2093
P1476
C3435T polymorphism in the MDR ...... g-donor liver transplantation.
@en
P2093
Hideyuki Saito
Ken-Ichi Inui
Koichi Tanaka
Satohiro Masuda
Shinji Uemoto
Tetsuya Kiuchi
P304
P356
10.1097/00008571-200208000-00005
P577
2002-08-01T00:00:00Z